Please enable JS

DISCOVER

ToTem4me

Success is when the time to access an innovative treatment is reduced.

ToTem4me is a multi-device application aiming at facilitating the recruitment of patients in clinical studies.

It assists the patients in detecting the studies close to their home for which they are potentially eligible according to their current health conditions.

Access ToTem4me

WHAT IS
ToTem4me?

A web app, with a high visibility as it is accessible on the AFA (the patient association in IBD in France) website.

A powerful algorithm, adapted with and for patients (Based on CT-SCCOUT™ technology & know-how).

“Live” support for the patients from a highly trained expert to identify the appropriate study in a convenient location.

LATEST NEWSOUR NEWS >

telemedecine technologies news

DMEA 2024 – Berlin

March 29, 2024

April 10 & 11, 2024 Telemedicine Technologies and OVHcloud are partnering to host health data collected in hospitals for medical research studies using the CleanWeb™ software suite. This collaboration allows Telemedicine Technologies to benefit from OVHcloud’s support, including 24/7 assistance and guarantees such as data localisation in France and transparency in data processing practices. DMEA […]

READ MORE
telemedecine technologies news

Improving Diversity in Clinical Trials

March 29, 2024

Applied Clinical Trials Online A lack of diversity in clinical trials is a critical issue, as racial and ethnic subgroups may respond differently to therapies, potentially undermining efficacy and safety outcomes and producing results that are not representative of the patients who will receive the treatment in the real world. Furthermore, clinical trials provide access […]

READ MORE
telemedecine technologies news

Innovation package: METAglut1 is reimbursed under common law

March 29, 2024

Mind health The startup Metafora Biosystems, which develops a platform for cellular metabolism analysis, announced on March 11th the reimbursement approval in France for its METAglut1 test, aiding in the diagnosis of Glut1 transporter deficiency syndrome since February 15th. This blood-based test is less invasive than the previously preferred lumbar puncture. It’s the first healthcare […]

READ MORE